Acromegaly is a serious endocrine disease associated ... including biochemical discrepancies, adverse effects of drugs and slowly developing recurrence). Such patients will, therefore, exhibit ...

However, fresh evidence from the HHS’ watchdog shows the problem is not a pushover FDA. If anything, the problem is a risk-averse agency too eager to say “no.” The Trump administration needs to make ...

while drugs can help reduce the levels of growth hormone that circulates in the body or stop the hormone from exerting its ...

More recently, pegylated drugs for the treatment of hepatitis C, acromegaly, rheumatoid arthritis, neutropenia, various cancers, wound healing, and other disorders either have been approved or are ...

The administration said that 64 drugs in total had prices that increased ... therapy for Cushing’s disease and acromegaly, which has seen its price rise faster than inflation every quarter ...

Both drugs are used to treat pituitary problems ... Meanwhile, Signifor LAR is a monthly depot formulation used to treat acromegaly, overgrowth of bone caused by a pituitary tumour that results ...